Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Wei

Showing results (31-40 of 99) with videos related to

Pageof 10
Sort By:
Haematologica|July 5, 2006
The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cellsAshley P Ng, Andrew Wei, Dinesh Bhurani, et al.
BMC Bioinformatics|February 4, 2010
Heuristics for the inversion median problemVaibhav Rajan, Andrew Wei Xu, Yu Lin, et al.
Leukemia Research|November 19, 2021
Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare systemCatriona Parker, Darshini Ayton, Ella Zomer, et al.
JCO Oncology Practice|May 12, 2021
Estimating the Productivity Impact of Acute Myeloid Leukemia in Australia Between 2020 and 2029, Using a Novel Work Utility Measure: The Productivity-Adjusted Life Year (PALY)Catriona Parker, Danny Liew, Zanfina Ademi, et al.
Leukemia Research|January 22, 2022
Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare systemCatriona Parker, Darshini Ayton, Ella Zomer, et al.
British Journal of Haematology|January 3, 2013
Utility of a clinical risk score to identify high-risk patients with de novo acute myeloid leukaemia in first remission after high-dose cytarabine (HiDAC) based induction chemotherapyVictoria Ling, Alan K Burnett, Ken Bradstock, et al.
Journal of the American Geriatrics Society|February 6, 2023
Automatable end-of-life screening for older adults in the emergency department using electronic health recordsAdrian D Haimovich, Wenxin Xu, Andrew Wei, et al.
Leukemia & Lymphoma|October 13, 2020
Double trouble or a silver lining? A case report of two patients with NPM1-mutated donor-derived acute myeloid leukemia (AML)Joanna Bao Ern Loh, Patricia Walker, Sharon Avery, et al.
Leukemia & Lymphoma|October 29, 2009
Disease status at autologous stem cell transplantation and the cell of origin phenotype are important predictors of outcome in patients with neurologic (central nervous system) relapse of diffuse large B-cell lymphoma undergoing autologous stem cell transplantationSushrut Patil, Andrew Spencer, Anthony Schwarer, et al.
Leukemia & Lymphoma|June 9, 2017
Phase Ib study of the mTOR inhibitor everolimus with low dose cytarabine in elderly acute myeloid leukemiaIng Soo Tiong, Peter Tan, Julie McManus, et al.
Pageof 10

Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
Haematologica|July 5, 2006
The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cellsAshley P Ng, Andrew Wei, Dinesh Bhurani, et al.
BMC Bioinformatics|February 4, 2010
Heuristics for the inversion median problemVaibhav Rajan, Andrew Wei Xu, Yu Lin, et al.
Leukemia Research|November 19, 2021
Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare systemCatriona Parker, Darshini Ayton, Ella Zomer, et al.
JCO Oncology Practice|May 12, 2021
Estimating the Productivity Impact of Acute Myeloid Leukemia in Australia Between 2020 and 2029, Using a Novel Work Utility Measure: The Productivity-Adjusted Life Year (PALY)Catriona Parker, Danny Liew, Zanfina Ademi, et al.
Leukemia Research|January 22, 2022
Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare systemCatriona Parker, Darshini Ayton, Ella Zomer, et al.
British Journal of Haematology|January 3, 2013
Utility of a clinical risk score to identify high-risk patients with de novo acute myeloid leukaemia in first remission after high-dose cytarabine (HiDAC) based induction chemotherapyVictoria Ling, Alan K Burnett, Ken Bradstock, et al.
Journal of the American Geriatrics Society|February 6, 2023
Automatable end-of-life screening for older adults in the emergency department using electronic health recordsAdrian D Haimovich, Wenxin Xu, Andrew Wei, et al.
Leukemia & Lymphoma|October 13, 2020
Double trouble or a silver lining? A case report of two patients with NPM1-mutated donor-derived acute myeloid leukemia (AML)Joanna Bao Ern Loh, Patricia Walker, Sharon Avery, et al.
Leukemia & Lymphoma|October 29, 2009
Disease status at autologous stem cell transplantation and the cell of origin phenotype are important predictors of outcome in patients with neurologic (central nervous system) relapse of diffuse large B-cell lymphoma undergoing autologous stem cell transplantationSushrut Patil, Andrew Spencer, Anthony Schwarer, et al.
Leukemia & Lymphoma|June 9, 2017
Phase Ib study of the mTOR inhibitor everolimus with low dose cytarabine in elderly acute myeloid leukemiaIng Soo Tiong, Peter Tan, Julie McManus, et al.
Pageof 10